While APOE4 dosage generally increases AD risk in women across races, the magnitude and manifestations of this effect differ by racial and ethnic background (Belloy et al., 2023; Tang et al., 1998) suggesting that findings from research focused predominantly on Caucasian populations may not fully capture sex-specific risks in diverse racial and ethnic groups. Here, APOE is linked to Alzheimer disease.